Skip to main content
Journal cover image

A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma.

Publication ,  Journal Article
Onaitis, M; D'Amico, TA; Clark, CP; Guinney, J; Harpole, DH; Rawlins, EL
Published in: Ann Thorac Surg
April 2011

BACKGROUND: One aspect of the cancer stem cell hypothesis is that patients with tumors that exhibit stem-like phenotypes have poor prognoses. Distal epithelial progenitors from lungs early in development demonstrate both self-renewal and potential to differentiate into all bronchial and alveolar epithelial cell types. By contrast, late progenitors are only able to produce alveolar cells. We sought to create a lung-specific progenitor cell signature for possible prognosis prediction in human lung cancer. METHODS: A transgenic mouse was created in which embryonic distal epithelial progenitor cells express green fluorescent protein when tamoxifen is administered. Lung progenitor cells were harvested after tamoxifen injection at either embryonic day 11.5 (E11.5) or 17.5 (E17.5). The RNA extracted from these cells was hybridized to Affymetrix 430.2 mouse chips (Affymetrix, Santa Clara, CA). A genomic signature was created by comparing the cell types using L1 logistic regression and applied to transcriptome datasets of resected patients from our tumor bank and the National Institutes of Health Director's Challenge Consortium. RESULTS: When a 10-gene genomic signature was applied to resected human adenocarcinoma datasets, tumors that were transcriptionally similar to the early progenitors had a significantly worse prognosis than those similar to the late progenitors. Using a Cox model in which age and stage were included, the predicted score from the logistic regression model was an independent predictor of survival. CONCLUSIONS: A lung progenitor cell signature predicts poor prognosis in lung adenocarcinoma. Modulation of these genes or their signaling pathways may be effective therapeutic strategies in the future.

Duke Scholars

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

April 2011

Volume

91

Issue

4

Start / End Page

1046 / 1050

Location

Netherlands

Related Subject Headings

  • Respiratory System
  • Prognosis
  • Neoplastic Stem Cells
  • Mice
  • Lung Neoplasms
  • Humans
  • Gene Expression Profiling
  • Animals
  • Adenocarcinoma
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Onaitis, M., D’Amico, T. A., Clark, C. P., Guinney, J., Harpole, D. H., & Rawlins, E. L. (2011). A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma. Ann Thorac Surg, 91(4), 1046–1050. https://doi.org/10.1016/j.athoracsur.2010.12.054
Onaitis, Mark, Thomas A. D’Amico, Cheryl P. Clark, Justin Guinney, David H. Harpole, and Emma L. Rawlins. “A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma.Ann Thorac Surg 91, no. 4 (April 2011): 1046–50. https://doi.org/10.1016/j.athoracsur.2010.12.054.
Onaitis M, D’Amico TA, Clark CP, Guinney J, Harpole DH, Rawlins EL. A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma. Ann Thorac Surg. 2011 Apr;91(4):1046–50.
Onaitis, Mark, et al. “A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma.Ann Thorac Surg, vol. 91, no. 4, Apr. 2011, pp. 1046–50. Pubmed, doi:10.1016/j.athoracsur.2010.12.054.
Onaitis M, D’Amico TA, Clark CP, Guinney J, Harpole DH, Rawlins EL. A 10-gene progenitor cell signature predicts poor prognosis in lung adenocarcinoma. Ann Thorac Surg. 2011 Apr;91(4):1046–1050.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

April 2011

Volume

91

Issue

4

Start / End Page

1046 / 1050

Location

Netherlands

Related Subject Headings

  • Respiratory System
  • Prognosis
  • Neoplastic Stem Cells
  • Mice
  • Lung Neoplasms
  • Humans
  • Gene Expression Profiling
  • Animals
  • Adenocarcinoma
  • 3202 Clinical sciences